Consistent with our previous results [7], Jilaveanu et al (2011) found that neither expression nor phosphorylation of SRC correlated with response to dasatinib in a panel of melanoma cell lines [5], therefore identifying the need for novel biomarkers of response to dasatinib. Here, SRC is linked to melanoma.